NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/11/2022
Back to search
Official data from USPTO
AXOVIA THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
04/14/2023
Trademark type
Combined
Nice classes
42
Filing date
02/25/2021
Registration date
10/11/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/11/2022
Last transaction
04/14/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/25/2021
First use in commerce
02/25/2021
Drawing code
3
Owner type
16
Owner location
Lake Forest, IL
Examiner
VALLILLO, MELISSA C
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "AXOVIA" in all caps stylized font with the upper right hash of the letter "X" elongated and curved downward with shadowing mirroring the curved hash above and below the hash and the lower shadow hash broken by the letter "O" in "AXOVIA", and the word "THERAPEUTICS" in smaller all caps immediately below the word "AXOVIA".
Holders and representatives
Holders
Jaguar Gene Therapy, LLC
Representatives
J. Dickson Phillips, III ROBINSON BRADSHAW & HINSON, P.A.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development in the field of gene therapy for the treatment of ciliopathies
Publications
History of USPTO decisions and trademark events.
31 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/11/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/07/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/06/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/11/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/10/2022
EX2G
SOU EXTENSION 2 GRANTED
08/10/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/06/2022
IUAF
USE AMENDMENT FILED
07/22/2022
EXT2
SOU EXTENSION 2 FILED
07/22/2022
EEXT
SOU TEAS EXTENSION RECEIVED
07/22/2022
EISU
TEAS STATEMENT OF USE RECEIVED
07/22/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/29/2022
EX1G
SOU EXTENSION 1 GRANTED
03/25/2022
EXT1
SOU EXTENSION 1 FILED
03/25/2022
EEXT
SOU TEAS EXTENSION RECEIVED
03/25/2022
DOCK
ASSIGNED TO EXAMINER
11/15/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/28/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/03/2021
PUBO
PUBLISHED FOR OPPOSITION
08/03/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/14/2021
ALIE
ASSIGNED TO LIE
06/28/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/25/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
06/24/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/24/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
06/24/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/24/2021
DOCK
ASSIGNED TO EXAMINER
06/21/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/10/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/09/2021
NWAP
NEW APPLICATION ENTERED
03/01/2021
Continuous trademark protection
Get notified about every new filing that threatens AXOVIA THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.